Dandekar Atul

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 19. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 19
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Maze Therapeutics, Inc.CSBOOption exercisenothing paid7,500 sharesOct 1, 2026Maze Therapeutics, Inc.CSBOnothing paidExercise · Oct 1Option exercise7,500Oct 1, 2026
Maze Therapeutics, Inc.CSBOOpen-market sell$202,9217,500 sharesOct 1, 2026Maze Therapeutics, Inc.CSBO$202,921Sell · Oct 1Open-market sell7,500Oct 1, 2026
Maze Therapeutics, Inc.CSBOOption exercise$78,1507,500 sharesOct 1, 2026Maze Therapeutics, Inc.CSBO$78,150Exercise · Oct 1Option exercise7,500Oct 1, 2026
Maze Therapeutics, Inc.CSBOOpen-market sell$92936 sharesSep 4, 2026Maze Therapeutics, Inc.CSBO$929Sell · Sep 4Open-market sell36Sep 4, 2026
Maze Therapeutics, Inc.CSBOOpen-market sell$83,4253,207 sharesSep 4, 2026Maze Therapeutics, Inc.CSBO$83,425Sell · Sep 4Open-market sell3,207Sep 4, 2026